Site icon Diseases Treatments Dictionary

Antiphospholipid syndrome (APS): causes, treatment and prevention

Definition

Antiphospholipid syndrome is an immune disorder in which abnormal antibodies are linked to abnormal blood clots in veins and arteries. It mostly affects the legs, but clots may also form in the kidneys, lungs and other organs. Antiphospholipid syndrome (APS) is also known as Antiphospholipid Antibody Syndrome, Hughes syndrome, or sticky blood.

 

History

Antiphospholipid syndrome was described in full in the 1980s, by Nigel Harris and Aziz Gharavi. They published the first papers in 1983. The syndrome was referred to as “Hughes syndrome” among colleagues after the rheumatologist Graham R.V. Hughes (St. Thomas’ Hospital, London, UK), who brought together the team.

Epidemiology

United States

The actual frequency of APS in the general population is unknown. One to 5% of healthy individuals have aPL antibodies. It is estimated that the incidence of APS is approximately 5 cases per 100,000 persons per year, and the prevalence is approximately 40-50 cases per 100, 000 persons. aCL antibodies tend to be found more frequently in elderly persons; thus, positive titer results should be interpreted with caution in this population. aPL antibodies are found in approximately 30-40% of patients with SLE, but only about 10% have APS. Approximately half of APS cases are not associated with another rheumatic disease. In a study of 100 patients with confirmed venous thrombosis and no history of SLE, aCL antibodies were found in 24% and LA in 4%. aPL syndrome is the cause of 14% of all strokes, 11% of myocardial infarctions, 10% of deep vein thromboses, 6% of pregnancy morbidity, and 9% of pregnancy losses.

International

International frequency is probably similar to US frequency.

Types of antiphospholipid syndrome

APS is divided into two types – primary and secondary:

Primary APS: More than half of people with APS have primary APS. This is APS on its own, and not associated with any other disease.

Secondary APS: This is APS that is associated with another disease, such as a rheumatic disease that affects the bones, joints or soft tissues. An example is systemic lupus erythematosus (SLE, or lupus). SLE seems to be the disease most commonly associated with APS. Many of the rheumatic diseases (including SLE) that are associated with APS are autoimmune diseases. This means that the immune system (which normally protects the body from infections) mistakenly attacks itself. This can cause symptoms and may damage the affected parts of the body.

Antiphospholipid syndrome – Risk factors

Antiphospholipid syndrome affects women much more than it does men. Other risk factors include:

Causes

The role of phospholipids

In antiphospholipid syndrome, your blood clots abnormally because your body mistakenly produces antibodies that attack phospholipids, a type of fat that plays a key role in clotting. Antibodies are proteins that normally protect the body against invaders, such as viruses and bacteria.

Antiphospholipid syndrome can be caused by an underlying condition, such as an autoimmune disorder, infection or certain medications, or you can develop the syndrome without an underlying cause.

Symptoms of antiphospholipid syndrome

Signs and symptoms of antiphospholipid syndrome can include:

Diagnosis and test

Treatment and medications

Treatment during pregnancy

Prevention of antiphospholipid syndrome

A patient with APS needs to take all possible measures to lower the risk of developing blood clots.

This includes:

Exit mobile version